Key result
Respiratory viral infections are increasingly recognized for their potential to lead to acute cardiovascular decompensations and systemic cardiovascular sequelae.
Answers are grounded in this paper and cite their sources.
Highlights the growing recognition of respiratory viral infections as precipitants of acute cardiovascular decompensation and long-term sequelae like heart failure.
The intersection between infectious diseases and cardiovascular outcomes has never been more pressing than in the post-COVID-19 pandemic era.Respiratory viral infections (RVIs)including influenza, SARS-CoV-2, and respiratory syncytial virus (RSV)-are increasingly recognized for their acute respiratory manifestations potentially leading to acute cardiovascular (CV) decompensations and systemic, particularly CV, sequelae.In their recent contribution to the European Journal of Preventive Cardiology, Wee et al. present compelling data quantifying the
No takes yet. Share an insight, caveat, or question.
Loubet et al. (2025) conducted an editorial in Respiratory viral infections and cardiovascular outcomes. Respiratory viral infections (RVIs) was evaluated. Respiratory viral infections are increasingly recognized for their potential to lead to acute cardiovascular decompensations and systemic cardiovascular sequelae.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: